Abound Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52K | Hold |
55
| – | – | ﹤0.01% | 774 |
|
|
2025
Q1 | $1.56K | Sell |
55
-3
| -5% | -$85 | ﹤0.01% | 724 |
|
|
2024
Q4 | $2.41K | Buy |
58
+7
| +14% | +$291 | ﹤0.01% | 655 |
|
|
2024
Q3 | $3.41K | Hold |
51
| – | – | ﹤0.01% | 625 |
|
|
2024
Q2 | $6.06K | Hold |
51
| – | – | ﹤0.01% | 456 |
|
|
2024
Q1 | $5.44K | Buy |
51
+3
| +6% | +$320 | ﹤0.01% | 502 |
|
|
2023
Q4 | $4.77K | Sell |
48
-12
| -20% | -$1.19K | ﹤0.01% | 517 |
|
|
2023
Q3 | $6.2K | Buy |
60
+13
| +28% | +$1.34K | ﹤0.01% | 418 |
|
|
2023
Q2 | $5.71K | Buy |
47
+2
| +4% | +$243 | ﹤0.01% | 452 |
|
|
2023
Q1 | $6.91K | Buy |
45
+9
| +25% | +$1.38K | ﹤0.01% | 342 |
|
|
2022
Q4 | $6.47K | Buy |
36
+11
| +44% | +$1.98K | ﹤0.01% | 316 |
|
|
2022
Q3 | $2.91K | Buy |
+25
| New | +$2.91K | ﹤0.01% | 434 |
|